ImmuCell Corporation (ICCC)
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.
$28.43M
Mr. Michael F. Brigham
64.00
Portland, ME
May 01, 1987
-6.98
$-0.52
0.29
2.37
-17.44%
-7.16
-1.03
1.24
1.25
0.77
-9.67%
-16.35%
Similar stocks (11)
Eliem Therapeutics, Inc.
ELYM
Rezolute, Inc.
RZLT
Lineage Cell Therapeutics, Inc.
LCTX
Fennec Pharmaceuticals Inc.
FENC
MediciNova, Inc.
MNOV
Anebulo Pharmaceuticals, Inc.
ANEB
Tempest Therapeutics, Inc.
TPST
HCW Biologics Inc.
HCWB
Cadrenal Therapeutics, Inc.
CVKD
Lipella Pharmaceuticals Inc.
LIPO
Protagenic Therapeutics, Inc.
PTIX
ETF Exposure (8)
iShares Micro-Cap ETF
IWC
0.0059%
Dimensional U.S. Targeted Value ETF
DFAT
4.3170000000000003e-4%
Dimensional U.S. Core Equity 2 ETF
DFAC
4.58e-6%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (11)
Eliem Therapeutics, Inc.
ELYM
Rezolute, Inc.
RZLT
Lineage Cell Therapeutics, Inc.
LCTX
Fennec Pharmaceuticals Inc.
FENC
MediciNova, Inc.
MNOV
Anebulo Pharmaceuticals, Inc.
ANEB
Tempest Therapeutics, Inc.
TPST
HCW Biologics Inc.
HCWB
Cadrenal Therapeutics, Inc.
CVKD
Lipella Pharmaceuticals Inc.
LIPO
Protagenic Therapeutics, Inc.
PTIX
ETF Exposure (8)
iShares Micro-Cap ETF
IWC
0.0059%
Dimensional U.S. Targeted Value ETF
DFAT
4.3170000000000003e-4%
Dimensional U.S. Core Equity 2 ETF
DFAC
4.58e-6%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%